ABX 1488Alternative Names: [18F]ABX-1488
Latest Information Update: 29 Aug 2016
At a glance
- Originator Abide Therapeutics
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Monoacylglycerol lipase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Neurological disorders